Sotera Health Co (NASDAQ:SHC)
| Market Cap | $4.54B-5.2% |
| Revenue (ttm) | $1.23B+6.9% |
| Net Income | $173.47M+213.0% |
| EPS | $0.60+209.6% |
| Shares Out | 285.17M |
| PE Ratio | 26.37 |
| Forward PE | 14.94 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,730,990 |
| Open | $16.18 |
| Previous Close | $16.21 |
| Day's Range | $15.81 - $16.31 |
| 52-Week Range | $13.09 - $19.85 |
| Beta | 1.93 |
| Analysts | Buy |
| Price Target | $21.00(+31.99%) |
| Earnings Date | Feb 23, 2027 |
About SHC
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
2 firms rating SHC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 23, 2027Earnings report
$SHC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SHC Revenue by Segment or Geography
| Sterigenics | $209.31M | 42.24% |
| Segment income | $170.66M | 34.44% |
| Nelson Labs | $60.56M | 12.22% |
| Nordion | $55.02M | 11.10% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New SHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SHC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SHC
| IJHiShares Core S&P Mid-Cap ETF | $163.59M |
| VTIVanguard Morningstar Total Stock Market ETF | $123.35M |
| VBVanguard Morningstar Small-Cap ETF | $110.38M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $61.76M |
| VXFVanguard Extended Market ETF | $58.73M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | $34.63M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from SHC’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| SMCP | SMART Mid Cap ETF | 2.40% |
| MIGO | MIG Core ETF | 2.23% |
| BSMC | Brandes U.S. Small-Mid Cap Value ETF | 1.06% |
| TSEE | T. Rowe Price Small Cap ETF | 0.90% |
| PJSM | PGIM Jennison Small-Mid Cap Core Equity ETF | 0.71% |
| BUYO | KraneShares Man Buyout Beta Index ETF | 0.60% |
| RFG | Invesco S&P MidCap 400 Pure Growth ETF | 0.52% |
| QSML | WisdomTree U.S. SmallCap Quality Growth Fund | 0.45% |
| NIXT | Research Affiliates Deletions ETF | 0.45% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.42% |
| TLCE | Thrivent Large Cap Stock ETF | 0.37% |
| MMCY.TO | Mackenzie Modus Cyclical Tilt ETF | 0.33% |
Weight is the stock’s share of each fund’s holdings.
